San Diego-based Allele sued Regeneron in 2021, accusing the rival biotech company of using Allele's fluorescent protein mNeonGreen to test its coronavirus antibody cocktail REGEN-COV without a ...

To put that in context, $5.14bn is 60.5% of Regeneron's full year revenues in 2020 of $8.5bn, and it is largely thanks to $2.76bn of revenue generated by its COVID therapy REGEN-COV which is ...

Dec 16 - Regeneron Pharmaceuticals (REGN.O), opens new tab has settled allegations that it misused a patented protein to test its COVID-19 treatment REGEN-COV, according to filings in New York ...

with REGEN-COV, and the viral burden was cut by 90 percent-plus, potentially helping halt the disease's spread. Regeneron booked around $260 million in U.S. government orders for the drug in the ...

president and chief scientific officer of Regeneron. Download the NBC News app for full coverage of the coronavirus outbreak The drugmaker also expects REGEN-COV to help people who respond poorly ...

Later this summer, Regeneron expects to submit a full Biologics License Application (BLA) for REGEN-COV. The development and manufacturing of REGEN-COV have been funded in part with federal funds ...

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) reported additional positive results from a phase 3 trial, which assessed use of a single dose of investigational REGEN-COV to prevent COVID-19.

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) said phase 3 RECOVERY trial has shown that in patients who had not made their own antibodies against SARS-CoV-2, treating them with REGEN-COV ...

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) Thursday said it stopped enrollment into the placebo group for its Phase 3 trial of REGEN-COV in non-hospitalised patients with COVID-19 as per ...

The hypocrisy never stops. Regeneron's monoclonal antibody treatment, REGEN-COV, is a mixture of two separate monoclonal antibodies—casirivimab and imdevimab. These antibodies are administered ...

Two of Regeneron’s blockbuster products, Eylea and Dupixent, experienced increased sales. But its REGEN-COV treatment for coronavirus was halted by regulatory agencies in the U.S. and Europe ...

Regeneron said its REGEN-COV treatment completely stopped symptomatic infections and cut overall rates of infections to about 50 percent in about 400 participants who were living with a COVID-19 ...